Lupin, Inc.
Quick facts
Phase 3 pipeline
- Lupin albuterol HFA MDI
- Reference Product (Spiriva®) · Respiratory / Pulmonology
Tiotropium is a long-acting anticholinergic (muscarinic antagonist) that relaxes airway smooth muscle and reduces mucus secretion to improve airflow in chronic obstructive pulmonary disease.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Lupin, Inc.
What is Lupin, Inc.'s pipeline?
Lupin, Inc. has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Lupin albuterol HFA MDI, Reference Product (Spiriva®).
Related
- Sector hub: All tracked pharma companies